Periodic Reporting for period 1 - RESTORE VISION (Novel advanced and repurposed therapeutics for vision restoration in a group of severe rare ocular surface diseases: from validation to first clinical investigations)

In Europe, approximately 30 million people suffer from blindness and visual impairment. Rare Eye Diseases (REDs) are a major cause of visual impairment and blindness affecting patients of all ages. Currently, many REDs have few treatments available which are often ineffective...